Oseltamivir treatment during influenza episodes is associated with a reduced risk for serious neuropsychiatric events among children and teens.

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.

Electronic cigarette (e-cigarette) flavor restriction policies are associated with reductions in e-cigarette use.